PharmaCyte Biotech, Inc.

PMCBNasdaqCIK: 0001157075

Over the 15 most recent insider filings, PharmaCyte Biotech, Inc. (PMCB) has seen activity from 5 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $128.7K bought versus $0 sold, a net purchase of $128.7K. Silverman Joshua (CEO and President, Director) is the most active by dollar volume, and the single largest transaction was $263.9K by Silverman Joshua. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume

$1.2M

Purchases

$128.7K

Sales

Unique Insiders

Price & Insider Trades

PMCB daily price over the past year with every insider buy and sale overlaid.

Price data is delayed and provided for context only — not investment advice.

Recent Insider Trades

15 loaded


Apr 2	PMCB PharmaCyte Biotech, Inc.	WALKER WAYNE REMELL	Director	Award	$79.8K
Jul 17	PMCB PharmaCyte Biotech, Inc.	Abecassis Michael M	Director	Other	$0
Apr 2	PMCB PharmaCyte Biotech, Inc.	Abecassis Michael M	Director	Award	$79.8K
Apr 2	PMCB PharmaCyte Biotech, Inc.	SCHECHTER JONATHAN	Director	Award	$79.8K
Jul 17	PMCB PharmaCyte Biotech, Inc.	SCHECHTER JONATHAN	Director	Other	$0
Jul 17	PMCB PharmaCyte Biotech, Inc.	WEINSTEIN ROBERT	Director	Other	$0
Jul 17	PMCB PharmaCyte Biotech, Inc.	WALKER WAYNE REMELL	Director	Other	$0
Apr 2	PMCB PharmaCyte Biotech, Inc.	WEINSTEIN ROBERT	Director	Award	$79.8K
Jan 7	PMCB PharmaCyte Biotech, Inc.	Silverman Joshua	CEO and President, Director	Buy	$80.5K
Jan 7	PMCB PharmaCyte Biotech, Inc.	SCHECHTER JONATHAN	Director	Buy	$48.2K
Dec 12	PMCB PharmaCyte Biotech, Inc.	Silverman Joshua	CEO and President, Director	Grant	$263.9K
Dec 12	PMCB PharmaCyte Biotech, Inc.	Abecassis Michael M	Director	Grant	$94.4K
Dec 12	PMCB PharmaCyte Biotech, Inc.	WALKER WAYNE REMELL	Director	Grant	$94.4K
Dec 12	PMCB PharmaCyte Biotech, Inc.	SCHECHTER JONATHAN	Director	Grant	$146.0K
Dec 12	PMCB PharmaCyte Biotech, Inc.	WEINSTEIN ROBERT	Director	Grant	$111.6K

15 filings